Literature DB >> 8088440

Myogenesis and the intermediate filament protein, nestin.

A M Kachinsky1, J A Dominov, J B Miller.   

Abstract

We show that the intermediate filament protein nestin is expressed in myogenic cells and that multiple mechanisms regulate nestin expression at different stages of myogenesis. Cultured embryonic, fetal, and neonatal mouse limb myoblasts initially expressed nestin in the absence of the four muscle regulatory factors (MRFs) of the MyoD family, whereas nestin and MRFs became coexpressed by myoblasts as culture duration was lengthened. Upon differentiation, nestin was commonly concentrated at the ends, and reduced or absent in the middles, of myotubes formed by mouse limb cells. Nestin was expressed by C2C12 and L6 myoblasts and was distributed throughout C2C12 myotubes, but was entirely absent in myotubes formed by L6 cells, suggesting that nestin is dispensable for fusion and terminal differentiation. Nestin was expressed in C3H10T1/2 cells, but was not expressed in 3T3-L1 cells until transfected with MyoD or myogenin. In mouse somites, nestin was found in both myotomal and dermatomal cells. Thus, nestin is expressed by dermatomal cells and by myoblasts during the earliest stages of myogenesis, and nestin expression can be activated upon MRF transfection. Additional MRF-independent mechanisms must, however, regulate nestin expression, because nestin is found in MRF-negative cells and, conversely, nestin is not uniformly distributed in MRF-expressing myotubes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8088440     DOI: 10.1006/dbio.1994.1248

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  33 in total

1.  Expression of the intermediate filament nestin in gastrointestinal stromal tumors and interstitial cells of Cajal.

Authors:  T Tsujimura; C Makiishi-Shimobayashi; J Lundkvist; U Lendahl; K Nakasho; A Sugihara; T Iwasaki; M Mano; N Yamada; K Yamashita; A Toyosaka; N Terada
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

Review 2.  Nestin in gastrointestinal and other cancers: effects on cells and tumor angiogenesis.

Authors:  Toshiyuki Ishiwata; Yoko Matsuda; Zenya Naito
Journal:  World J Gastroenterol       Date:  2011-01-28       Impact factor: 5.742

3.  Dopaminergic neuronal conversion from adult rat skeletal muscle-derived stem cells in vitro.

Authors:  Jian Yang; Xuan Wang; Yue Wang; Zi-Xuan Guo; Ding-Zhen Luo; Jun Jia; Xiao-Min Wang
Journal:  Neurochem Res       Date:  2012-06-22       Impact factor: 3.996

Review 4.  Desmin cytoskeleton in healthy and failing heart.

Authors:  Y Capetanaki
Journal:  Heart Fail Rev       Date:  2000-10       Impact factor: 4.214

5.  An essential role for heat shock transcription factor binding protein 1 (HSBP1) during early embryonic development.

Authors:  Binnur Eroglu; Jin-Na Min; Yan Zhang; Edyta Szurek; Demetrius Moskophidis; Ali Eroglu; Nahid F Mivechi
Journal:  Dev Biol       Date:  2013-12-28       Impact factor: 3.582

Review 6.  Intermediate filaments in the nervous system: implications in cancer.

Authors:  C L Ho; R K Liem
Journal:  Cancer Metastasis Rev       Date:  1996-12       Impact factor: 9.264

7.  Heterogeneity of neural progenitor cells revealed by enhancers in the nestin gene.

Authors:  P J Yaworsky; C Kappen
Journal:  Dev Biol       Date:  1999-01-15       Impact factor: 3.582

8.  The expression of nestin delineates skeletal muscle differentiation in the developing rat esophagus.

Authors:  Peng-Han Su; Tung-Cheng Wang; Zong-Ruei Wong; Bu-Miin Huang; Hsi-Yuan Yang
Journal:  J Anat       Date:  2011-03       Impact factor: 2.610

9.  Pancreatic cancer with Nest-in tendencies.

Authors:  Sophia L Maund; Scott D Cramer
Journal:  Cancer Biol Ther       Date:  2011-03-15       Impact factor: 4.742

10.  Cdk5 regulates the organization of Nestin and its association with p35.

Authors:  Cecilia M Sahlgren; Andrey Mikhailov; Samuli Vaittinen; Hanna-Mari Pallari; Hannu Kalimo; Harish C Pant; John E Eriksson
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.